Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
AIRNA Therapeuticsairna.comAIRNA is a biotechnology company developing novel RNA editing therapeutics for rare and common diseases. Their lead candidate AIR 001 targets alpha-1 antitrypsin deficiency, while their cardiometabolic portfolio aims to reduce LDL cholesterol through RNA editing.
Parse Score
